chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Fatigue; Arm pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Apr2021 15:00 (Lot number: EW0150) at the age of 40 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: TRELEGY; SINGULAIR; FLONASE [FLUTICASONE PROPIONATE]; AMBIEN; ALBUTEROL [SALBUTAMOL]. The following information was reported: FATIGUE (non-serious) with onset Apr2021, outcome "not recovered", described as "Fatigue"; PAIN IN EXTREMITY (non-serious) with onset Apr2021, outcome "not recovered", described as "Arm pain". Therapeutic measures were not taken as a result of fatigue, pain in extremity.  Additional Information: No known allergies. No other vaccine in four weeks. Unknown if she got Covid prior vaccination. Not Covid tested post vaccination.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021497049 Same reporter/patient/vaccine, different dose/events
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Vaccination site erythema, Vaccination site rash
Clinical narrative: Dizziness; headache; big red circle under injection site/rash, and then clarified that it is a big, red circle; big red circle under injection site/rash, and then clarified that it is a big, red circle; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65 year-old female patient received bnt162b2 (BNT162B2), administration date 03Apr2021 (Lot number: EP1533) at the age of 65 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1, Lot number: EN6205), administration date: 13Mar2021, when the patient was 65 years old, for Covid-19 Immunization. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE RASH (non-serious) all with onset 09Apr2021, outcome "recovering" and all described as "big red circle under injection site/rash, and then clarified that it is a big, red circle"; DIZZINESS (non-serious) with onset 23Apr2021, outcome "not recovered", described as "Dizziness"; HEADACHE (non-serious) with onset 23Apr2021, outcome "not recovered", described as "headache". Therapeutic measures were not taken as a result of vaccination site erythema, vaccination site rash, dizziness, headache.  No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan, Vaccination site pain
Clinical narrative: Soreness at injection site after first vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 07Apr2021 (Lot number: ER8131) at the age of 39 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Autoimmune" (unspecified if ongoing), notes: 2 years ago she had an ultrasound and was told she had a minor autoimmune. The patient took concomitant medications. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset Apr2021, outcome "recovered" (Apr2021), described as "Soreness at injection site after first vaccine". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient was taking a birth control pill and a multivitamin. The patient had no prior vaccinations within 4 weeks. With the first dose of the COVID Vaccine the patient stated she only had soreness at the injection site. It lasted for about 2 days and she could not sleep on that side of her body. Patient was not visited to Emergency Room or Physician Office .  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Stress
Clinical narrative: I am suddenly exhausted.; I am stressed; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60 year-old patient received bnt162b2 (BNT162B2) (Lot number: EN6199) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: AMLODIPINE; GLIPIZIDE; GABAPENTIN; ATORVASTATIN. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "I am suddenly exhausted."; STRESS (non-serious), outcome "unknown", described as "I am stressed".  No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure abnormal, Blood pressure measurement
Clinical narrative: blood pressure went up very high for a while and then it kept on going up and down for about a week; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71 year-old male patient received bnt162b2 (BNT162B2), administration date 27Mar2021 (Lot number: ER8730, Expiration Date: Jul2021) at the age of 70 years as dose 1, single and administration date 17Apr2021 (Batch/Lot number: unknown, Expiration Date: Jul2021) as dose 2, single for covid-19 immunisation. Relevant medical history included: "High blood pressure" (unspecified if ongoing), notes: about 20 years ago. The patient's concomitant medications were not reported. The following information was reported: BLOOD PRESSURE ABNORMAL (non-serious) with onset 28Mar2021, outcome "recovering", described as "blood pressure went up very high for a while and then it kept on going up and down for about a week". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of blood pressure abnormal.  Additional information: He wanted to report a possible side effect to a Pfizer COVID Vaccine. About a day later he have his first shot and his blood pressure went up very high for a while and then it kept on going up and down for about a week and now he felt fine." Date of adverse event: Consumer stated, "That was last Monday. That was 19th of April. He took the last shot on the 17th of April" (Further not clarified, hence not captured in tab). LOT# (Second one): Consumer stated, "It looks like CW0161." Treatment in response to event: Consumer stated, "He was taking the blood pressure pills. He do not want to get involved in all that."  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: got her a little sick/the first one made her sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A female patient received bnt162b2 (BNT162B2), administration date 26Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "sinus problems" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "got her a little sick/the first one made her sick".  Additional information: This consumer reported for his daughter (patient). Reporter stated his daughter had the same problems noting the headache is in the same place and that her temperature has backed off. Reporter stated the first dose got her a little sick and the second dose she was in the bed for a couple of days. Reporter wanted to know how long these side effects last. The Reporter was the patient's father. The reporter was reporting about the COVID shot. Stated his daughter had the same reaction but she does not have a temperature anymore. He says she had the same dates as both of his. In his report he said his first dose was on 26Mar2021 and his second dose was on 23Apr2021. He says she had the second one, the first one made her sick, the second one gave her a headache and temperature, but she has no more temperature today. Reporter seriousness for sick was unspecified. He told her about is headache and temperature and she said she had it too. The headache is on the top of her head. He says they both have sinus problems, but this is not a sinus issue. This was a cloned case, report 2 of 2.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Bed rest, Body temperature abnormal, Headache, Nausea
Clinical narrative: the headache is in the same place; her temperature has backed off; she was in the bed for a couple of days; little bit of nausea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A female patient received bnt162b2 (BNT162B2), administration date 23Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose no:1), administration date: 26Mar2021, for Covid-19 Immunization. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "the headache is in the same place"; BODY TEMPERATURE ABNORMAL (non-serious), outcome "recovered", described as "her temperature has backed off"; BED REST (non-serious), outcome "unknown", described as "she was in the bed for a couple of days"; NAUSEA (non-serious), outcome "unknown", described as "little bit of nausea". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Caller stated about the COVID shot and he reports AE on himself and mentions during his call that his daughter had the same reaction but she does not have a temperature anymore. He says she had the same dates as both of his. In his report he said his first dose was on 26Mar2021 and his second dose was on 23Apr2021. He says she had the second one, the first one made her sick, the second one gave her a headache and temperature but she has no more temperature today. He says they both have sinus problems but this is not a sinus issue.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Migraine, Pain in extremity
Clinical narrative: arm hurt; migraine; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: HEADACHE (non-serious) with onset 14Apr2021, outcome "unknown", described as "headache"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "arm hurt"; MIGRAINE (non-serious) with onset 14Apr2021, outcome "recovering", described as "migraine".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Eating disorder, Trismus
Clinical narrative: couldnt open her jaw; hard to eat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 68 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 68 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TRISMUS (non-serious), outcome "unknown", described as "couldnt open her jaw"; EATING DISORDER (non-serious), outcome "unknown", described as "hard to eat".  Additional information: The reporter who was the cousin of the patient stated that, she was unaware of how long the symptoms started and lasted. The reporter called the patient and she was talking so according to the reporter, the patient must have felt better. The reporter does not know exact birthdate of the patient and the year but reporter believed it was 14 May.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Eating disorder, Trismus
Clinical narrative: couldnt open her jaw; having a hard time eating; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient in her 70's received bnt162b2 (BNT162B2) (Lot number: Unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "A-Fib" (unspecified if ongoing), notes: Verbatim: A-Fib. The patient's concomitant medications were not reported. The following information was reported: TRISMUS (non-serious), outcome "unknown", described as "couldnt open her jaw"; EATING DISORDER (non-serious), outcome "unknown", described as "having a hard time eating".  Additional Information: Caller states that she was talking to her cousin and she states that she couldn't open her jaw/mouth after getting the vaccine, and was having a hard time eating. He cousin stated that her sister said she had the same problem. Caller stated she does not know where this patient got vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pain in extremity
Clinical narrative: Full-body aches; Extreme fatigue; Arm pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 26Apr2021 12:15 (Lot number: EW0164) at the age of 40 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: TRELEGY; SINGULAIR; FLONASE [FLUTICASONE PROPIONATE]; AMBIEN; ALBUTEROL [SALBUTAMOL SULFATE]. Vaccination history included: Bnt162b2 (dose 1, single, lot number=EW0150, administration time=03:00 PM, vaccine location=Left arm), administration date: 05Apr2021, when the patient was 40 years old, for Covid-19 Immunization, reaction(s): "Fatigue", "Arm pain". The following information was reported: PAIN (non-serious) with onset 26Apr2021, outcome "not recovered", described as "Full-body aches"; FATIGUE (non-serious) with onset 26Apr2021, outcome "not recovered", described as "Extreme fatigue"; PAIN IN EXTREMITY (non-serious) with onset 26Apr2021, outcome "not recovered", described as "Arm pain". Therapeutic measures were not taken as a result of pain, fatigue, pain in extremity.  Additional information: There were no known allergies. Facility type Vaccine was Hospital. The patient did not receive other vaccine in four weeks. It was unknown whether the patient had covid prior vaccination. The patient did not test covid post vaccination.   No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Paraesthesia oral
Clinical narrative: After 2nd dose my tongue felt tingly, then the inside of my mouth was numb. It felt like I had novocaine. It numbness was in several areas in my mouth; After 2nd dose my tongue felt tingly, then the inside of my mouth was numb. It felt like I had novocaine. It numbness was in several areas in my mouth; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 25Mar2021 12:30 (Lot number: EP7534) at the age of 52 years as dose 2, single and (Batch/Lot number: unknown) for 1 day for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: FLONASE ALLERGY RELIEF; CLARITINE; LIPITOR; TYLENOL PM; CBD OIL. Vaccination history included: Bnt162b2 (product=COVID 19, brand=Pfizer,, lot_number=EN6202,,, administration_time=12:30 PM,, dose_number=1,, vaccine_location=Left arm), administration date: 04Mar2021, when the patient was 52 years old, for COVID-19 immunization, reaction(s): "Metallic taste in mouth".  The following information was reported: PARAESTHESIA ORAL (non-serious), HYPOAESTHESIA ORAL (non-serious) all with onset 25Mar2021, outcome "recovered" (2021) and all described as "After 2nd dose my tongue felt tingly, then the inside of my mouth was numb. It felt like I had novocaine. It numbness was in several areas in my mouth". Therapeutic measures were not taken as a result of paraesthesia oral, hypoaesthesia oral.  Additional information: The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Reported Event: After 1st dose there was a metallic taste in my mouth. After 2nd dose my tongue felt tingly, then the inside of my mouth was numb. It felt like I had novocaine. It numbness was in several areas in my mouth. It lasted several hours. My sister had the same reaction but her throat was closing and she had to go to the hospital. My throat did not close. Prior to vaccination, the patient did not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: minor headache; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 49-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing). The patient's concomitant medications were not reported.  The following information was reported: HEADACHE (non-serious), outcome "recovered", described as "minor headache".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore shoulder; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose number: 1), for COVID-19 immunization. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Sore shoulder".  Additional information: Patient reported he had his first dose last Friday and second on 14May. Sore shoulder for a day but no side effects from first dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Facial pain, Hypertonia
Clinical narrative: feeling tension/pressure in same area on left side of face; feeling tension/pressure in same area on left side of face; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 14Apr2021 14:45 (Lot number: ER8729) at the age of 39 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Menstrual cycle abnormal" (unspecified if ongoing); "Seasonal allergies" (unspecified if ongoing). Concomitant medication(s) included: LO LOESTRIN FE taken for menstrual disorder (ongoing); FLONASE [FLUTICASONE PROPIONATE] taken for seasonal allergy (ongoing). Vaccination history included: Bnt162b2 (dose 1 at 2:45 pm, via intramuscular administered on left arm. Batch/lot number: ER8733), administration date: 24Mar2021, for COVID-19 Immunisation, reaction(s): "numbness and tingling in her face", "numbness and tingling in her face", "pressure/tightness", "face became flushed". The following information was reported: HYPERTONIA (non-serious), FACIAL PAIN (non-serious) all with onset 14Apr2021 17:00, outcome "recovering" and all described as "feeling tension/pressure in same area on left side of face". Therapeutic measures were not taken as a result of hypertonia, facial pain. Additional information: Prior patient vaccinations was reported as none.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Vaccination site pain
Clinical narrative: Sore arm; Felt a little tired; nauseated; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (001774). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Cancer" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Sore arm"; FATIGUE (non-serious), outcome "unknown", described as "Felt a little tired"; NAUSEA (non-serious), outcome "unknown", described as "nauseated".  Additional information: Patient had sore arm the next day and felt a little tired and nauseated but it was very short lived. Patient also had cancer so was expecting to be little worse.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Minor muscle pain; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYALGIA (non-serious), outcome "unknown", described as "Minor muscle pain".  Additional Information: Patient had minor muscle pain after 1st shot. Nothing after shot 2.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysstasia, Feeling hot
Clinical narrative: May 2nd I woke up with dizziness until today May 4th, I can't stay stand much time because I get so dizzy.; May 2nd I woke up with dizziness until today May 4th, I can't stay stand much time because I get so dizzy.; I felt the face warm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01May2021 11:00 (Batch/Lot number: unknown) at the age of 31 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING HOT (non-serious) with onset 01May2021 10:00, outcome "not recovered", described as "I felt the face warm"; DIZZINESS (non-serious) with onset 02May2021 10:00, outcome "not recovered", DYSSTASIA (non-serious) with onset 04May2021 10:00, outcome "not recovered" and all described as "May 2nd I woke up with dizziness until today May 4th, I can't stay stand much time because I get so dizzy.". Therapeutic measures were not taken as a result of feeling hot, dizziness, dysstasia.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, has the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: he experienced arm pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 08Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "he experienced arm pain". Additional information: The patient received his 2nd dose 30Apr2021, and he was currently experiencing body pain. He wants to know if he can take a pain reliever similar to Tylenol.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Skin exfoliation
Clinical narrative: Hands were peeling really badly; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (002591). The reporter is the patient.  A 66 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SKIN EXFOLIATION (non-serious), outcome "unknown", described as "Hands were peeling really badly". Additional information: due to getting the COVID Vaccine shot, her hands were peeling really badly, felt like a chemical peel.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Eyelid function disorder, Pain in extremity, Peripheral swelling, Vertigo
Clinical narrative: Vertigo; Crazy dizziness; Some arm pain; Big toe swole up; she can't shut her eyes because the dizziness is so bad; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 40 year-old female patient received bnt162b2 (BNT162B2), administration date 27Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 immunization. The following information was reported: VERTIGO (non-serious) with onset Apr2021, outcome "not recovered", described as "Vertigo"; DIZZINESS (non-serious) with onset 2021, outcome "not recovered", described as "Crazy dizziness"; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "Some arm pain"; PERIPHERAL SWELLING (non-serious) with onset 2021, outcome "unknown", described as "Big toe swole up"; EYELID FUNCTION DISORDER (non-serious) with onset 2021, outcome "not recovered", described as "she can't shut her eyes because the dizziness is so bad".  Additional information: Patient received the second dose of the Pfizer COVID vaccine seven days ago and she is still having vertigo and crazy dizziness. It has been constant but comes and goes away since receiving the vaccine. It was reported that the vertigo started between 7-10 hours after receiving the second dose of the vaccine. patient cannot shut her eyes because the dizziness is so bad. She never had dizziness or vertigo before receiving the vaccine. Caller states this has been known as COVID toe and she called (pharmacy name withheld) and they told her that was a normal side effect. Patient wanted to know if dizziness and vertigo has been reported as a side effect, if side effects usually last two to three days and what she should do about her side effects.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: body pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 30Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), administration date: 08Apr2021, for Covid-19 Immunization, reaction(s): "arm pain". The following information was reported: PAIN (non-serious) with onset 30Apr2021, outcome "unknown", described as "body pain".  Additional information: The patient received his 1st dose on 08Apr2021 and he experienced arm pain. Today, he received his 2nd dose 30Apr2021, and he was currently experiencing body pain. He wanted to know if he can take a pain reliever similar to Tylenol.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Caller has ringing of the ears; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TINNITUS (non-serious), outcome "unknown", described as "Caller has ringing of the ears".  Additional information: She has ringing of the ears and got her 1st dose of the Covid vaccine and wants to report it. Medical Information: Were any unaddressed medical questions referred or forwarded to Medical Information: No.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Lethargy, Myalgia, Vaccination site pain
Clinical narrative: First dose- Injection site soreness; Mild muscle aching and lethargy 18 hours after the first dose.; Mild muscle aching and lethargy 18 hours after the first dose.; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old male patient received bnt162b2 (BNT162B2), administration date Apr2021 (Lot number: ER8727, EW0173) at the age of 51 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset Apr2021, outcome "recovered" (2021), described as "First dose- Injection site soreness"; MYALGIA (non-serious), LETHARGY (non-serious) all with onset Apr2021, outcome "recovered" (2021) and all described as "Mild muscle aching and lethargy 18 hours after the first dose.". It was unknown if therapeutic measures were taken as a result of vaccination site pain, myalgia, lethargy.  Additional information: First dose- Injection site soreness, Mild muscle aching and lethargy 18 hours after the first dose. Headache, nausea and vomiting 42 hours past second dose- lasted for 7 hours. if other vaccine was administered in four weeks was unknown. It was unknown, if patient had covid prior vaccination and if covid tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Abnormal dreams, Illusion
Clinical narrative: Dreams, dreams, dreams. Love what you are doing and my dreams are more realistic, has clarity, etc.; seeing things in my bedroom that arent there; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A female patient in her 50's (not pregnant) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ABNORMAL DREAMS (non-serious), outcome "unknown", described as "Dreams, dreams, dreams. Love what you are doing and my dreams are more realistic, has clarity, etc."; ILLUSION (non-serious), outcome "unknown", described as "seeing things in my bedroom that arent there".  Additional information: Action taken as result of reaction: If patient take a full Tylenol pm, she start to sleep walk. After her 2 vaccines, she noticed her dreams was almost in same state. She believed she had a frog on her blanket. She had having full length conversations in her dreams that she would not have before. She believe she was seeing things in her bedroom that was not there. No enquiry involve a report of exposure during pregnancy.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: Tired; Injection site soreness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 51 year-old female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) at the age of 51 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: FATIGUE (non-serious) with onset 2021, outcome "recovered" (2021), described as "Tired"; VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "recovered" (2021), described as "Injection site soreness".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite
Clinical narrative: had no appetite at all/Loss of appetite; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 02May2021 11:30 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, single, MANUFACTURER UNKNOWN), for covid-19 immunisation. The following information was reported: DECREASED APPETITE (non-serious) with onset 03May2021, outcome "unknown", described as "had no appetite at all/Loss of appetite".  Additional information: The patient stated that the day of his second dose he felt fine. The next day, yesterday, he stated that he had no appetite at all reported, he had no hunger pangs like he usually did when he was hungry. The patient did not feel hungry at all. There was a small window where he might have felt a little hungry around dinner but that was it. The patient then stated that he still had no appetite today either and he was concerned because he did not see this side effect listed as commonly reported with the Pfizer COVID-19 vaccine. The patient denied any nausea associated with his lack of appetite. No other side effects.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Condition aggravated, Obsessive-compulsive disorder
Clinical narrative: My anxiety\OCD issues, after the shot, became more intense and prolonged.; My anxiety\OCD issues, after the shot, became more intense and prolonged.; My anxiety\OCD issues, after the shot, became more intense and prolonged.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 17 year-old female patient (not pregnant) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and administered in arm left, administration date 10Apr2021 09:30 (Lot number: EW0158) as dose 1, single for covid-19 immunisation. Relevant medical history included: "OCD" (unspecified if ongoing); "Anxiety" (unspecified if ongoing). Concomitant medication(s) included: ESCITALOPRAM; CEPHALEXINE; MUPIROCIN. The following information was reported: CONDITION AGGRAVATED (non-serious), OBSESSIVE-COMPULSIVE DISORDER (non-serious), ANXIETY (non-serious) all with onset 11Apr2021 08:00, outcome "recovering" and all described as "My anxiety\OCD issues, after the shot, became more intense and prolonged.". The event "my anxiety\ocd issues, after the shot, became more intense and prolonged.", "my anxiety\ocd issues, after the shot, became more intense and prolonged." and "my anxiety\ocd issues, after the shot, became more intense and prolonged." was evaluated at the physician office visit. Therapeutic measures were taken as a result of condition aggravated, obsessive-compulsive disorder, anxiety.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. List of other medications the patient received within 2 weeks of vaccination were reported as Escitalopram 10mg, Cephalexin 500mg, Mupirocin 2%. It was reported that the patient haven't had this bad of an attack in quite a long time. It happened again after the 2nd shot. Treatment was reported as Counseling appointment. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Impaired work ability, Migraine
Clinical narrative: migraine; unable to function due to the pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program . The reporter is the parent. Other Case identifier(s): US-PFIZER INC-2021494042 (Pfizer).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single and administration date 26Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MIGRAINE (non-serious), outcome "not recovered", described as "migraine"; IMPAIRED WORK ABILITY (non-serious), outcome "unknown", described as "unable to function due to the pain".  Additional information: Reporter stated his son (patient) received COVID Vaccine doses 1 and 2. Patient acquired a migraine with the first dose hat never cleared his Migraine has now become debilitating since he received 2nd vaccine on 26 April. He has never suffered from migraines in the past. Asking that is this a side effect from vaccines and if so why isn't the public told. This vaccine has taken a very health active young man and turned him into a person unable to function due to the pain. What can be done or prescribed by his doctor to help clear them.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Paraesthesia
Clinical narrative: pain to left legs; tingly feeling to your feet; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient (reported as 38) received bnt162b2 (BNT162B2), administration date 15Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "pain to left legs"; PARAESTHESIA (non-serious), outcome "unknown", described as "tingly feeling to your feet". The events "pain to left legs" and "tingly feeling to your feet" were evaluated at the emergency room visit. Therapeutic measures were taken as a result of pain in extremity, paraesthesia.  Additional information: Reporter complaining of pain to left legs and tingly feeling to feet for 21 days. He went to an urgent care and they examined him and told him that he have no swelling in leg. And asked have these side effects been reported. Reporter asked was that okay for him to take Ibuprofen that was prescribed for him from the urgent care clinic.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Paraesthesia
Clinical narrative: pain to the left leg; tingly feeling to his feet; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38 year-old male patient received bnt162b2 (BNT162B2), administration date 15Apr2021 (Lot number: EW0169) at the age of 38 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "pain to the left leg"; PARAESTHESIA (non-serious) with onset 2021, outcome "unknown", described as "tingly feeling to his feet". The events "pain to the left leg" and "tingly feeling to his feet" were evaluated at the emergency room visit. Therapeutic measures were taken as a result of pain in extremity, paraesthesia.  Additional Information: The patient received first dose of Pfizer Covid Vaccine on 15Apr2021 and he is complaining of pain to the left leg and a tingly feeling to his feet, specifically his left pinky toe. He went to urgent care and they examined him and told him there was nothing wrong with his leg and prescribed him Ibuprofen.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Neck pain
Clinical narrative: neck pain near the clavicle area; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A male patient received bnt162b2 (BNT162B2), administered in arm left (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 Immunization. The following information was reported: NECK PAIN (non-serious), outcome "unknown", described as "neck pain near the clavicle area".  Additional information: Reporter stated that, patient received the second dose Pfizer COVID vaccine on his left arm on Sunday around 16:30 or 17:00. Patient was having pain kind of like in the neck area, stated in the past half hour and patient is pointed to his left clavicle area, so it's not in the vaccination site, it's kind of like up from it in the neck area, and it really hurts. Patient did not receive other products. Patient's mother was worried that the vaccination was not properly administrated to the patient, and she wants to give Tylenol to the patient and response received: There are reports of muscle pain (38.3%) and joint pain (23.6%), no specific reports of neck pain, this does not necessarily mean that the vaccination could not cause this.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Condition aggravated, Myalgia, Sciatica
Clinical narrative: A lot of pain, in her muscles; Muscle pain symptoms had worsened after the 1st dose; sciatic nerve pain; back pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 57 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "back surgeries" (unspecified if ongoing), notes: history of 2 back surgeries. The patient's concomitant medications were not reported. The following information was reported: MYALGIA (non-serious), outcome "unknown", described as "A lot of pain, in her muscles"; CONDITION AGGRAVATED (non-serious), outcome "unknown", described as "Muscle pain symptoms had worsened after the 1st dose"; SCIATICA (non-serious), outcome "unknown", described as "sciatic nerve pain"; BACK PAIN (non-serious), outcome "unknown", described as "back pain". The events "a lot of pain, in her muscles", "muscle pain symptoms had worsened after the 1st dose", "sciatic nerve pain" and "back pain" were evaluated at the emergency room visit.  Additional information: Patient reported that her muscle pain symptoms have worsened after the 1st dose that she was taken to the emergency room twice. Patient was worried since she was due for her 2nd dose today and has gotten better, but still experiencing back pain.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.